These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
253 related articles for article (PubMed ID: 26002317)
1. Uveitis secondary to leishmaniasis immune reconstitution syndrome in a HIV-positive patient. Davies O; Allen F; Gruener AM; Simons R; Graham EM; Larbalestier N Int J STD AIDS; 2016 Jun; 27(7):598-600. PubMed ID: 26002317 [TBL] [Abstract][Full Text] [Related]
2. Post-kala-azar dermal Leishmaniasis and uveitis in an HIV-positive patient. Ramos A; Cruz I; Muñez E; Salas C; Fernández A; Alvarez-Espejo T Infection; 2008 Mar; 36(2):184-6. PubMed ID: 18327683 [No Abstract] [Full Text] [Related]
3. Immune reconstitution visceral leishmaniasis presented as hemophagocytic syndrome in a patient with AIDS from a nonendemic area: a case report. Patel KK; Patel AK; Sarda P; Shah BA; Ranjan R J Int Assoc Physicians AIDS Care (Chic); 2009; 8(4):217-20. PubMed ID: 19535493 [TBL] [Abstract][Full Text] [Related]
4. Leishmaniasis (PKDL) as a case of immune reconstitution inflammatory syndrome (IRIS) in HIV-positive patient after initiation of anti-retroviral therapy (ART). Tadesse A; Hurissa Z Ethiop Med J; 2009 Jan; 47(1):77-9. PubMed ID: 19743785 [TBL] [Abstract][Full Text] [Related]
5. Cutaneous leishmaniasis associated with visceral leishmaniasis in a case of acquired immunodeficiency syndrome (AIDS). Pourahmad M; Hooshmand F; Rahiminejad M Int J Dermatol; 2009 Jan; 48(1):59-61. PubMed ID: 19126052 [TBL] [Abstract][Full Text] [Related]
6. An unusual case of post-kala-azar dermal leishmaniasis in a patient with HIV and visceral leishmaniasis co-infection. Elliott T; Simpson J; Naresh KN; Lockwood D; Bailey AC Int J STD AIDS; 2019 Oct; 30(12):1221-1223. PubMed ID: 31558131 [No Abstract] [Full Text] [Related]
7. Atypical disseminated leishmaniasis resembling post-kala-azar dermal leishmaniasis in an HIV-infected patient. Boumis E; Chinello P; Della Rocca C; Paglia MG; Proietti MF; Petrosillo N Int J STD AIDS; 2006 May; 17(5):351-3. PubMed ID: 16643688 [TBL] [Abstract][Full Text] [Related]
8. Post-kala-azar dermal leishmaniasis in HIV-coinfected individuals: problems in diagnosis and treatment. Ramesh V; Avishek K; Salotra P Int J Dermatol; 2015 Jan; 54(1):116-20. PubMed ID: 25209701 [No Abstract] [Full Text] [Related]
9. Diffuse cutaneous leishmaniasis associated with the immune reconstitution inflammatory syndrome. Sinha S; Fernández G; Kapila R; Lambert WC; Schwartz RA Int J Dermatol; 2008 Dec; 47(12):1263-70. PubMed ID: 19126013 [TBL] [Abstract][Full Text] [Related]
10. Immune restoration disease associated with Leishmania donovani infection following antiretroviral therapy for HIV infection. Auyeung P; French MA; Hollingsworth PN J Microbiol Immunol Infect; 2010 Feb; 43(1):74-6. PubMed ID: 20434127 [TBL] [Abstract][Full Text] [Related]
12. [Visceral leishmaniasis and HIV infection: the diagnostic and therapeutic problems]. Rocha PS; Rebocho L; Alvoeiro L; Lourenço G; Branco R; Victorino RM; de Moura MC Acta Med Port; 1993 Nov; 6(11):543-6. PubMed ID: 8140923 [TBL] [Abstract][Full Text] [Related]
13. Atypical manifestations of visceral leishmaniasis in patients with HIV in north Ethiopia: a gap in guidelines for the management of opportunistic infections in resource poor settings. Diro E; van Griensven J; Mohammed R; Colebunders R; Asefa M; Hailu A; Lynen L Lancet Infect Dis; 2015 Jan; 15(1):122-9. PubMed ID: 25300862 [TBL] [Abstract][Full Text] [Related]
14. Challenges in HIV and visceral Leishmania co-infection: future research directions. Ejara ED; Lynen L; Boelaert M; Van Griensven J Trop Med Int Health; 2010 Oct; 15(10):1266-7. PubMed ID: 20723183 [No Abstract] [Full Text] [Related]
15. [First case in Russia of coinfection of visceral leishmaniasis and HIV-infection]. Konstantinova TN; Lysenko AIa; Lavdovskaia MV; Imamkuliev KD; Sel'kova EP; Anchukova EL; Ageenko TA Ter Arkh; 1998; 70(11):31-3. PubMed ID: 9949454 [No Abstract] [Full Text] [Related]
16. Development of visceral leishmaniasis in an HIV(+) patient upon immune reconstitution following the initiation of antiretroviral therapy. Schleenvoigt BT; Ignatius R; Baier M; Schneider T; Weber M; Hagel S; Forstner C; Pletz MW Infection; 2016 Feb; 44(1):115-9. PubMed ID: 26123228 [TBL] [Abstract][Full Text] [Related]
17. Pleural and peritoneal leishmaniasis in an AIDS patient. Muñoz-Rodríguez FJ; Padró S; Pastor P; Rosa-Re D; Valls ME; Miró JM; Gatell JM Eur J Clin Microbiol Infect Dis; 1997 Mar; 16(3):246-8. PubMed ID: 9131331 [TBL] [Abstract][Full Text] [Related]
18. Visceral leishmaniasis in human immunodeficiency virus (HIV)-infected and non-HIV-infected patients. A comparative study. Pintado V; Martín-Rabadán P; Rivera ML; Moreno S; Bouza E Medicine (Baltimore); 2001 Jan; 80(1):54-73. PubMed ID: 11204503 [TBL] [Abstract][Full Text] [Related]
19. Visceral leishmaniasis in HIV infection and AIDS: clinical features and response to therapy. Peters BS; Fish D; Golden R; Evans DA; Bryceson AD; Pinching AJ Q J Med; 1990 Nov; 77(283):1101-11. PubMed ID: 2274656 [TBL] [Abstract][Full Text] [Related]
20. The role of splenectomy in HIV-infected patients with relapsing visceral leishmaniasis. Troya J; Casquero A; Muñiz G; Fernández-Guerrero ML; Górgolas M Parasitology; 2007 May; 134(Pt 5):621-4. PubMed ID: 17156583 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]